Based on the results obtained by PS-α-PD-L1 antibody treatments on ovarian tumor-cell growth inhibition in vitro, we investigated the effects of targeting intracellular PD-L1 with a cell-penetrating antibody on ovarian tumor growth in vivo. This evidence concerns the gene CD274 and ovarian neoplasm.